A detailed history of Essex Financial Services, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Essex Financial Services, Inc. holds 211,388 shares of PFE stock, worth $5.57 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
211,388
Previous 295,723 28.52%
Holding current value
$5.57 Million
Previous $8.27 Million 26.07%
% of portfolio
0.3%
Previous 0.4%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$27.7 - $31.39 $2.34 Million - $2.65 Million
-84,335 Reduced 28.52%
211,388 $6.12 Million
Q2 2024

Aug 09, 2024

SELL
$25.26 - $29.6 $34,353 - $40,256
-1,360 Reduced 0.46%
295,723 $8.27 Million
Q2 2024

Jul 31, 2024

BUY
$25.26 - $29.6 $952,832 - $1.12 Million
37,721 Added 14.54%
297,083 $8.31 Million
Q1 2024

Apr 23, 2024

SELL
$25.89 - $29.73 $306,874 - $352,389
-11,853 Reduced 4.37%
259,362 $7.2 Million
Q4 2023

Feb 05, 2024

SELL
$26.13 - $33.94 $177,474 - $230,520
-6,792 Reduced 2.44%
271,215 $7.81 Million
Q3 2023

Nov 15, 2023

BUY
$32.09 - $37.51 $894,893 - $1.05 Million
27,887 Added 11.15%
278,007 $9.22 Million
Q2 2023

Aug 08, 2023

SELL
$36.12 - $41.79 $208,845 - $241,629
-5,782 Reduced 2.26%
250,120 $9.17 Million
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $139,322 - $181,377
-3,537 Reduced 1.36%
255,902 $10.4 Million
Q4 2022

Feb 10, 2023

BUY
$41.75 - $54.5 $22,127 - $28,885
530 Added 0.2%
259,439 $13.3 Million
Q3 2022

Nov 07, 2022

BUY
$43.76 - $53.42 $167,163 - $204,064
3,820 Added 1.5%
258,909 $11.3 Million
Q2 2022

Aug 01, 2022

SELL
$46.53 - $55.17 $37,968 - $45,018
-816 Reduced 0.32%
255,089 $13.4 Million
Q1 2022

Apr 21, 2022

BUY
$45.75 - $56.69 $121,054 - $150,001
2,646 Added 1.04%
255,905 $13.2 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $201,848 - $299,206
4,885 Added 1.97%
253,259 $15 Million
Q3 2021

Nov 10, 2021

BUY
$39.25 - $50.42 $3.06 Million - $3.94 Million
78,065 Added 45.84%
248,374 $10.7 Million
Q1 2021

May 11, 2021

SELL
$33.49 - $37.77 $15,137 - $17,072
-452 Reduced 0.26%
170,309 $6.17 Million
Q4 2020

Feb 05, 2021

BUY
$33.47 - $42.56 $193,188 - $245,656
5,772 Added 3.5%
170,761 $6.29 Million
Q3 2020

Nov 10, 2020

BUY
$31.75 - $37.25 $512,699 - $601,513
16,148 Added 10.85%
164,989 $6.06 Million
Q2 2020

Aug 06, 2020

BUY
$30.12 - $36.54 $1.11 Million - $1.35 Million
36,863 Added 32.92%
148,841 $4.87 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $36,220 - $51,750
-1,340 Reduced 1.18%
111,978 $3.66 Million
Q4 2019

Jan 30, 2020

SELL
$32.92 - $37.36 $73,345 - $83,238
-2,228 Reduced 1.93%
113,318 $4.44 Million
Q3 2019

Nov 04, 2019

SELL
$32.49 - $42.13 $4.46 Million - $5.78 Million
-137,214 Reduced 54.29%
115,546 $4.15 Million
Q2 2019

Jul 30, 2019

BUY
$36.98 - $41.52 $88,382 - $99,232
2,390 Added 0.95%
252,760 $11 Million
Q1 2019

May 02, 2019

SELL
$37.5 - $41.2 $626,850 - $688,699
-16,716 Reduced 6.26%
250,370 $10.6 Million
Q4 2018

Feb 07, 2019

SELL
$38.47 - $43.86 $1.59 Million - $1.81 Million
-41,324 Reduced 13.4%
267,086 $11.7 Million
Q3 2018

Nov 05, 2018

SELL
$34.47 - $41.81 $782,020 - $948,543
-22,687 Reduced 6.85%
308,410 $13.6 Million
Q2 2018

Aug 07, 2018

BUY
$32.98 - $35.16 $107,152 - $114,234
3,249 Added 0.99%
331,097 $12 Million
Q1 2018

May 03, 2018

SELL
$31.91 - $37.02 $229,464 - $266,210
-7,191 Reduced 2.15%
327,848 $11.6 Million
Q4 2017

Feb 07, 2018

SELL
$33.26 - $35.29 $261,024 - $276,955
-7,848 Reduced 2.29%
335,039 $12.1 Million
Q3 2017

Nov 03, 2017

BUY
$31.0 - $34.15 $422,685 - $465,635
13,635 Added 4.14%
342,887 $12.2 Million
Q2 2017

Aug 07, 2017

BUY
N/A
329,252
329,252 $11.1 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Essex Financial Services, Inc. Portfolio

Follow Essex Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Essex Financial Services, Inc. with notifications on news.